A Community Bio-Tech Lab Offers a Crash Course in Designing Life — Open to the Public
By Adam Wernick,
PRI
| 06. 05. 2015
Untitled Document
“Scientists in general are awful at communicating their work to the general public,” says Jorgensen, the director of Genspace. “The consumer is already using genetically modified and genetically engineered products in their daily life. So, wouldn't it be nice if the end user were also someone who could have a say about what this technology was used for?“
Genspace, which opened in downtown Brooklyn in 2009, is the world's first community bio-lab. It offers a three-class crash course in synthetic biology to anyone who is interested. It also has a working lab space where the general public is invited to come in and learn how to do genetic science — hands on.
At Genspace, Wetherell experimented with her own DNA. Here her DNA is suspended in an agarose gel that is charged by an electical current that separates the proteins
Credit: Julia Wetherell
For $100 a month, Genspace members have access to the standardized gene sets that are the building blocks of synthetic biology. If that sounds daunting, consider this: Non-scientists make up a big part of...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...
